M28 Capital Management LP Adagio Therapeutics, Inc. Transaction History
M28 Capital Management LP
- $86.7 Million
- Q2 2024
A detailed history of M28 Capital Management LP transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, M28 Capital Management LP holds 9,248,250 shares of ADGI stock, worth $30.6 Million. This represents 35.29% of its overall portfolio holdings.
Number of Shares
9,248,250
Previous 9,248,250
-0.0%
Holding current value
$30.6 Million
Previous $30.6 Million
-0.0%
% of portfolio
35.29%
Previous 28.73%
Shares
3 transactions
Others Institutions Holding ADGI
# of Institutions
86Shares Held
67.3MCall Options Held
700KPut Options Held
600-
Lee Ainslie Maverick Capital LTD | Dallas, Tx11.8MShares$38.9 Million0.77% of portfolio
-
Deep Track Capital, LP Greenwich, CT11MShares$36.3 Million1.19% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$14.2 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY3.74MShares$12.4 Million0.24% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...